Maximising recruitment into randomised controlled trials: The role of multidisciplinary cancer teams

被引:45
作者
McNair, A. G. K. [1 ,2 ,3 ]
Choh, C. T. P. [2 ]
Metcalfe, C. [1 ]
Littlejohns, D. [4 ]
Barham, C. P. [2 ]
hollowood, A. [2 ]
Falk, S. J. [5 ]
Blazeby, J. M. [1 ,2 ,3 ]
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] Univ Hosp Bristol NHS Fdn, Div Head & Neck Surg, Bristol BS2 8HW, Avon, England
[3] Bristol Royal Infirm & Gen Hosp, Clin Sci S Bristol, Bristol BS2 8HW, Avon, England
[4] Univ Bristol, Fac Med & Dent, Bristol BS2 8DZ, Avon, England
[5] Univ Hosp Bristol NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol BS2 8HW, Avon, England
关键词
Multidisciplinary teams; Oesophageal cancer; Randomised controlled trials; Recruitment;
D O I
10.1016/j.ejca.2008.08.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multidisciplinary cancer teams offer many theoretical benefits, although few have been formally examined. This study evaluated the role of multidisciplinary team (MDT) meetings in recruitment into randomised controlled trials (RCTs). Consecutive MDT patient records were categorised into those with or without a recommendation for a national multicentre RCT, Clinical trial office records identified whether patients were subsequently screened and randomised. In 125 MDT meetings, 350 new patients were discussed, of whom 103 were potentially suitable for a RCT. The MDT recommended 68 patients for the trial, of whom 58 (85%) were screened for trial eligibility. Of the 35 without an MDT trial recommendation, only 23 (66%) were screened (p = 0.022). This difference persisted and resulted in a greater proportion of MDT recommended patients being recruited (65% versus 49%; p = 0.12). This study demonstrates that trial recommendation by an MDT significantly increases trial screening rates and may improve recruitment. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2623 / 2626
页数:4
相关论文
共 23 条
  • [1] Campbell MK, 2007, HEALTH TECHNOL ASSES, V11
  • [2] Why don't cancer patients enter clinical trials?: A review
    Castel, Patrick
    Negrier, Sylvie
    Boissel, Jean-Pierre
    [J]. EUROPEAN JOURNAL OF CANCER, 2006, 42 (12) : 1744 - 1748
  • [3] Rate limiting factors in recruitment of patients to clinical trials in cancer research: descriptive study
    Corrie, P
    Shaw, J
    Harris, R
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7410): : 320 - 321
  • [4] FAYTER D, 2006, 31 U YORK CRD
  • [5] Multidisciplinary teams in cancer care: are they effective in the UK?
    Fleissig, Anne
    Jenkins, Valerie
    Catt, Susan
    Fallowfield, Lesley
    [J]. LANCET ONCOLOGY, 2006, 7 (11) : 935 - 943
  • [6] Improving cancer control in the European Union: Conclusions from the Lisbon round-table under the Portuguese EU Presidency, 2007
    Gouveia, Joaquim
    Coleman, Michel P.
    Haward, Robert
    Zanetti, Roberto
    Hakama, Matti
    Borras, Josep Maria
    Primic-Zakelj, Maja
    de Koning, Harry J.
    Travado, Luzia
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (10) : 1457 - 1462
  • [7] Greene FL., 2002, AJCC CANC STAGING MA
  • [8] Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness
    Haward, R
    Amir, Z
    Borrill, C
    Dawson, J
    Scully, J
    West, M
    Sainsbury, R
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 15 - 22
  • [9] MANAGEMENT OF OVARIAN-CANCER - REFERRAL TO A MULTIDISCIPLINARY TEAM MATTERS
    JUNOR, EJ
    HOLE, DJ
    GILLIS, CR
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (02) : 363 - 370
  • [10] The Brain Tumor Board:: Lessons to be learned from an interdisciplinary conference
    Lutterbach, J
    Pagenstecher, A
    Spreer, J
    Hetzel, A
    van Velthoven, V
    Nikkhah, G
    Frommhold, H
    Volk, B
    Schumacher, M
    Lücking, C
    Zentner, J
    Ostertag, C
    [J]. ONKOLOGIE, 2005, 28 (01): : 22 - 26